Cash & equivalents increased 39.1%
Cash & equivalents changed +39.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +39.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +32.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +72.9% from the comparable as-filed period.
Free-cash-flow proxy changed +59.5% from the comparable as-filed period.
Operating cash flow changed +54.5% from the comparable as-filed period.
Current liabilities changed +77.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed +78.3% from the comparable as-filed period.
Gross margin changed +546 basis points from the comparable as-filed period.
Operating margin changed +2104 basis points from the comparable as-filed period.
Research & development changed +29.5% from the comparable as-filed period.
Working capital / assets changed +148 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed +23.9% from the comparable as-filed period.
Trade receivables changed +15.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross profit changed +33.1% from the comparable as-filed period.
SBC / revenue changed -841 basis points from the comparable as-filed period.
Receivables / revenue changed -926 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed -43.2% from the comparable as-filed period.
Free-cash-flow margin changed +823 basis points from the comparable as-filed period.
Operating cash-flow margin changed +744 basis points from the comparable as-filed period.
Stock-based compensation changed -21.3% from the comparable as-filed period.
Current ratio changed -25.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed -79 basis points from the comparable as-filed period.
R&D / revenue changed +221 basis points from the comparable as-filed period.
Shares outstanding changed +4.2% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
Working capital changed +5.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Total assets changed -0.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Cost of revenue changed -2.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.